![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FNIP2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1609892 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FNIP2 mRNA | CTD | PMID:36331819 | FNIP2 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1609892 | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of FNIP2 mRNA | CTD | PMID:22206623 | FNIP2 | Human | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1562174 | 6480464 | Ethinyl Estradiol results in increased expression of FNIP2 mRNA | CTD | PMID:29097150 | FNIP2 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of FNIP2 mRNA | CTD | PMID:21185374|PMID:31614463 | FNIP2 | Human | 17beta-estradiol | increases expression | ISO | RGD:1562174 | 6480464 | Estradiol results in increased expression of FNIP2 mRNA | CTD | PMID:35192832 | FNIP2 | Human | 17beta-estradiol | decreases expression | ISO | RGD:1609892 | 6480464 | Estradiol results in decreased expression of FNIP2 mRNA | CTD | PMID:39298647 | FNIP2 | Human | 17beta-estradiol | affects expression | ISO | RGD:1562174 | 6480464 | Estradiol affects the expression of FNIP2 mRNA | CTD | PMID:32145629 | FNIP2 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FNIP2 mRNA | CTD | PMID:23146750 | FNIP2 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FNIP2 protein | CTD | PMID:31675489 | FNIP2 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | ISO | RGD:1609892 | 6480464 | [Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of more ... | CTD | PMID:38995820 | FNIP2 | Human | 2,3,4,7,8-Pentachlorodibenzofuran | decreases expression | ISO | RGD:1562174 | 6480464 | 2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of FNIP2 mRNA | CTD | PMID:21724226 | FNIP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1562174 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FNIP2 mRNA | CTD | PMID:22298810 | FNIP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1562174 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FNIP2 mRNA | CTD | PMID:33387578 | FNIP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1609892 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FNIP2 mRNA | CTD | PMID:28922406 | FNIP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FNIP2 mRNA | CTD | PMID:20106945|PMID:21632981 | FNIP2 | Human | 2,4,6-tribromophenol | decreases expression | EXP | | 6480464 | 2,4,6-tribromophenol results in decreased expression of FNIP2 mRNA | CTD | PMID:31675489 | FNIP2 | Human | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of FNIP2 mRNA | CTD | PMID:30851411 | FNIP2 | Human | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of FNIP2 protein | CTD | PMID:31675489 | FNIP2 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1609892 | 6480464 | bisphenol S results in decreased expression of FNIP2 mRNA | CTD | PMID:33297965|PMID:39298647 | FNIP2 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of FNIP2 gene | CTD | PMID:31601247 | FNIP2 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:1562174 | 6480464 | Propylthiouracil results in decreased expression of FNIP2 mRNA | CTD | PMID:24780913 | FNIP2 | Human | acetamide | decreases expression | ISO | RGD:1562174 | 6480464 | acetamide results in decreased expression of FNIP2 mRNA | CTD | PMID:31881176 | FNIP2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of FNIP2 gene | CTD | PMID:27153756 | FNIP2 | Human | aflatoxin B1 | decreases expression | ISO | RGD:1562174 | 6480464 | Aflatoxin B1 results in decreased expression of FNIP2 mRNA | CTD | PMID:33354967 | FNIP2 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of FNIP2 mRNA | CTD | PMID:21934132|PMID:23724009|PMID:33167477 | FNIP2 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of FNIP2 mRNA | CTD | PMID:24449571 | FNIP2 | Human | arsane | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | FNIP2 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | FNIP2 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of FNIP2 mRNA | CTD | PMID:27829220 | FNIP2 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of FNIP2 mRNA | CTD | PMID:20106945|PMID:21632981 | FNIP2 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of FNIP2 promoter | CTD | PMID:27901495 | FNIP2 | Human | bisphenol A | decreases expression | ISO | RGD:1562174 | 6480464 | bisphenol A results in decreased expression of FNIP2 mRNA | CTD | PMID:25181051 | FNIP2 | Human | bisphenol A | affects expression | ISO | RGD:1562174 | 6480464 | bisphenol A affects the expression of FNIP2 mRNA | CTD | PMID:30903817|PMID:32145629 | FNIP2 | Human | bisphenol A | increases expression | ISO | RGD:1562174 | 6480464 | bisphenol A results in increased expression of FNIP2 mRNA | CTD | PMID:29097150|PMID:30816183|PMID:32528016 | FNIP2 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of FNIP2 protein | CTD | PMID:35688186 | FNIP2 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of FNIP2 mRNA | CTD | PMID:25979313 | FNIP2 | Human | carbon nanotube | increases expression | ISO | RGD:1609892 | 6480464 | Nanotubes, Carbon analog results in increased expression of FNIP2 mRNA | CTD | PMID:25554681 | FNIP2 | Human | carbon nanotube | decreases expression | ISO | RGD:1609892 | 6480464 | Nanotubes, Carbon results in decreased expression of FNIP2 mRNA | CTD | PMID:25620056 | FNIP2 | Human | chloroprene | increases expression | ISO | RGD:1562174 | 6480464 | Chloroprene results in increased expression of FNIP2 mRNA | CTD | PMID:23125180 | FNIP2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FNIP2 mRNA | CTD | PMID:20106945|PMID:27989131 | FNIP2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FNIP2 mRNA | CTD | PMID:25562108 | FNIP2 | Human | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of FNIP2 protein | CTD | PMID:31675489 | FNIP2 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of FNIP2 mRNA | CTD | PMID:27829220 | FNIP2 | Human | diclofenac | decreases expression | ISO | RGD:1609892 | 6480464 | Diclofenac results in decreased expression of FNIP2 mRNA | CTD | PMID:26934552 | FNIP2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | FNIP2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of FNIP2 mRNA | CTD | PMID:29803840 | FNIP2 | Human | endosulfan | increases expression | ISO | RGD:1562174 | 6480464 | Endosulfan results in increased expression of FNIP2 mRNA | CTD | PMID:29391264 | FNIP2 | Human | epoxiconazole | decreases expression | ISO | RGD:1609892 | 6480464 | epoxiconazole results in decreased expression of FNIP2 mRNA | CTD | PMID:35436446 | FNIP2 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of FNIP2 mRNA | CTD | PMID:23649840 | FNIP2 | Human | fipronil | increases expression | ISO | RGD:1562174 | 6480464 | fipronil results in increased expression of FNIP2 mRNA | CTD | PMID:34044035 | FNIP2 | Human | fluoranthene | multiple interactions | ISO | RGD:1609892 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of FNIP2 mRNA | CTD | PMID:28329830 | FNIP2 | Human | folic acid | decreases expression | ISO | RGD:1609892 | 6480464 | Folic Acid results in decreased expression of FNIP2 mRNA | CTD | PMID:25629700 | FNIP2 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of FNIP2 mRNA | CTD | PMID:20655997 | FNIP2 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of FNIP2 mRNA | CTD | PMID:23649840 | FNIP2 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of FNIP2 protein | CTD | PMID:37730182 | FNIP2 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of FNIP2 gene | CTD | PMID:31601247 | FNIP2 | Human | gentamycin | increases expression | ISO | RGD:1562174 | 6480464 | Gentamicins results in increased expression of FNIP2 mRNA | CTD | PMID:33387578 | FNIP2 | Human | glyphosate | increases methylation | ISO | RGD:1562174 | 6480464 | Glyphosate results in increased methylation of FNIP2 gene | CTD | PMID:31011160 | FNIP2 | Human | GSK-J4 | increases expression | EXP | | 6480464 | GSK-J4 results in increased expression of FNIP2 mRNA | CTD | PMID:29301935 | FNIP2 | Human | manganese atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | FNIP2 | Human | manganese(0) | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | FNIP2 | Human | manganese(II) chloride | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | FNIP2 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of FNIP2 mRNA | CTD | PMID:23649840 | FNIP2 | Human | paracetamol | increases expression | ISO | RGD:1562174 | 6480464 | Acetaminophen results in increased expression of FNIP2 mRNA | CTD | PMID:33387578 | FNIP2 | Human | parathion | increases expression | ISO | RGD:1609892 | 6480464 | Parathion results in increased expression of FNIP2 mRNA | CTD | PMID:34813904 | FNIP2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1609892 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FNIP2 mRNA | CTD | PMID:36331819 | FNIP2 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of FNIP2 mRNA | CTD | PMID:22714537 | FNIP2 | Human | propiconazole | decreases expression | ISO | RGD:1609892 | 6480464 | propiconazole results in decreased expression of FNIP2 mRNA | CTD | PMID:21278054 | FNIP2 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of FNIP2 mRNA | CTD | PMID:21632981 | FNIP2 | Human | quinolin-8-ol | increases expression | EXP | | 6480464 | Oxyquinoline results in increased expression of FNIP2 mRNA | CTD | PMID:21632981 | FNIP2 | Human | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of FNIP2 mRNA | CTD | PMID:30851411 | FNIP2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | FNIP2 | Human | silicon dioxide | increases expression | ISO | RGD:1609892 | 6480464 | Silicon Dioxide results in increased expression of FNIP2 mRNA | CTD | PMID:29203145 | FNIP2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of FNIP2 mRNA | CTD | PMID:38568856 | FNIP2 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | FNIP2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of FNIP2 mRNA | CTD | PMID:31533062 | FNIP2 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of FNIP2 mRNA | CTD | PMID:38568856 | FNIP2 | Human | titanium dioxide | increases expression | ISO | RGD:1609892 | 6480464 | titanium dioxide results in increased expression of FNIP2 mRNA | CTD | PMID:29264374 | FNIP2 | Human | trichloroethene | increases expression | ISO | RGD:1562174 | 6480464 | Trichloroethylene results in increased expression of FNIP2 mRNA | CTD | PMID:33387578 | FNIP2 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of FNIP2 mRNA | CTD | PMID:24935251|PMID:26272509 | FNIP2 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | FNIP2 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of FNIP2 mRNA | CTD | PMID:30510588 | FNIP2 | Human | triphenyl phosphate | increases expression | ISO | RGD:1562174 | 6480464 | triphenyl phosphate results in increased expression of FNIP2 mRNA | CTD | PMID:30589522 | FNIP2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of FNIP2 mRNA | CTD | PMID:37042841 | FNIP2 | Human | Triptolide | decreases expression | ISO | RGD:1609892 | 6480464 | triptolide results in decreased expression of FNIP2 mRNA | CTD | PMID:32835833 | FNIP2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of FNIP2 mRNA | CTD | PMID:28818685 | FNIP2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FNIP2 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:26272509 | FNIP2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | FNIP2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of FNIP2 mRNA | CTD | PMID:27188386 | |